Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide Combined With Short-term CSII in Newly-diagnosed Type 2 Diabetes
NCT01790308Phase 4Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Feb 2013
- Primary completion
- Dec 2014
- Modality
- Peptides
01
Overview
Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Percentage of patients who maintain glucose control at 1 year. Status: unknown.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01790308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01790308.